Using clinicopathologic data, we demonstrated that higher‐grade tumors display significant upregulation of ATAD2 and SMARCA4 expression, and downregulation of SMARCA2 expression, which further confirms a universal relation of these BrD proteins' expression with cancer stemness. The gene discussed is ATAD2; the disease is cancer.